Results from ongoing study suggest the major role of Celartics' Cov-DCVax in preventing viral infection of COVID-19 and in controlling progression of the virus-associated diseasesBeijing, May 22, 2020, Celartics Biopharma announced today the filing of a patent application covering a novel dendritic cell (DC)-based vaccine, Cov-DCVax, to fight viral infection of COVID-19. The results, led by Celart
薔蜜轉彎「明天最靠近」!下波變天時間曝 全台有雨
06-01
全台成濕番薯!這天起迎「連10天降雨模式」
06-01
6月超旺!4生肖事業財運齊揚 貴人助攻迎運勢巔峰
06-01
獨家/吳老師戴墨鏡整復 稱「引神之氣助人」惹議
06-01













